BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (http://bmjopen.bmj.com/site/about/resources/checklist.pdf) and are provided with free text boxes to elaborate on their assessment. These free text comments are reproduced below.
GENERAL COMMENTS
The protocol describes a proposed systematic review and metaanalysis of studies comparing right-and left-sided thoracic esophagectomy for esophageal cancer. Both RCTs and non-RCTs will be eligible. I have a few statistical comments but all of these can be addressed.
3.6 Data analysis 1) Heterogeneity is common in meta-analysis -and indeed, heterogeneity is expected where randomised and non-randomised comparisons are included. Identifying and describing these differences is valuable, but difficult where there are few studies (eg less than 10). It is also difficult to interpret an overall difference in the presence of large heterogeneity. The chi-squared test and I^2 can help, but a clinical narrative is more important: please describe qualitatively the differences and possible causes.
2) The proposed analyses states "If there is high heterogeneity...we will use the random effect model to analyze the extracted data. Otherwise, we will adopt fixed-effect model to analyze the data." The stated methods (Mantel-Haenszel and Inverse Variance) are both fixed effect analyses. Presumably the random effects method will be the DerSimonian & Laird model (as implemented in RevMan and Stats's metan respectively), but please state this. There are also two typographical errors in the the text ("with the 95% confidence interval" rather than "within the 95% confidence interval")
3) Please consider the use of SMD for the time-to-event outcomes. The measurement units (time in years) are the same for the trials, so it may not be helpful to divide the mean differences by the SD. Alternatively if hazard ratios are available (or can be obtained -see Parmar et al 1998 and Cochrane guidance), these can be combined using the generic inverse method or random effects equivalent. I agree that the SMD is the most appropriate way to combine QoL though since these are likely to be measured using different instruments.
3.7 Publication bias "If publication bias is suspected in a trial, we will consult the corresponding author via email to determine whether there is publication bias." Do you mean to determine reporting bias? Reporting bias occurs when outcomes are selectively not included in a report (for example, if only the "significant" outcomes are reported). Publication bias is where there is no report at all (for example, the report was not submitted or not accepted because the results were not "significant"). Reporting bias can be addressed by obtaining extra data from the authors, but this is unlikely to help with publication bias. The trim and fill method is a sensitivity analysis and should be identified as such in 3.6.2. 
This manuscript is the study protocol for a systematic review and meta-analysis on rght versus left thoracic approach esophagectomy for esophageal cancer. There are some problems in this manuscript. 1. Page 7, Line 7-13 is incorrect. This is the study to compare and meta-analyze right and left thoracic approach for esophageal cancer. 2.
Page 8: 3.1.2 and 3.1.3 The authors reported that the participants of this study will be patients who were treated with video-assisted thoracoscopic esophagectomy in Types of participants, whereas they will target all types of right versus left thoracic esophagectomy in Types of intervention. Which is true?
VERSION 1 -AUTHOR RESPONSE
Respond to reviewer 1 Thanks for your comments and guidance. We have made appropriate revisions to this protocol according to your comments. While revising the manuscript, we have learned a lot of new knowledge, which will help us carry out the following work smoothly and provide high-quality evidence for clinicians. Best regards.
Respond to reviewer 2
We have appropriately revised this protocol in accordance with your comments, and accurately described and defined the participants to be included in this study. Thank you for your comments and guidance. Best regards.
Changes in manuscript 1.We have revised the manuscript in accordance with all the comments of two reviewers and editor. 2.Because of the need of this study, we have revised the order and number of authors and corresponding author email address. 3.In the strengths and limitations of this study, the first statement is incorrect, and we have revised it. 4.In the author contributions, the English expression format of the author's name is not correct, we have corrected it.
VERSION 2 -REVIEW

REVIEWER
Mike Bradburn University of Sheffield, UK REVIEW RETURNED 16-Apr-2019
GENERAL COMMENTS
The comments in my previous review have been partly addressed.
3.6 Comments 1) and 3) do not appear to be addressed. Neither are mandatory but I believe both would improve the review. In particular a clinical narrative will be helpful if few trials are identified and hetergeineity is substantial; formal meta-regression won't help in this (likely) situation.
Comment 2: The additional text is appropriate, but needs minor grammatical modification 3.7 The revised sentence "If reporting bias is suspected in a trial, we will consult the corresponding author via email to determine whether there is reporting bias."
The authors might want to phrase this statement to something more neutral! perhaps "If reporting bias is suspected in a trial, we will contact the corresponding author via email to find out whether there are additional outcome data which were not reported."
REVIEWER
Masayuki Watanabe
Department of Gastroenterological Surgery, Cancer Institute Hospital REVIEW RETURNED 21-Apr-2019
GENERAL COMMENTS the authors appropriately revised the manuscript.
